methyl 7-bromo-5H-imidazo[1,2-b]pyrazole-3-carboxylate, 97%, 100mg

6-chloro-N~4~-methyl-2,4-pyrimidinediamine, 95.0%, 10g

1,5,6,7-Tetrahydro-2-methyl-4H-indol-4-one>98.0%(GC)25g

(S)-1-Methylpyrrolidine-3-carboxylic acid, 95.0%, 250mg

(S)-1-((1S,3aR,4S,7aR)-4-((tert-Butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)ethan-1-ol, 98%, 25mg

3-[(2S)-PIPERIDIN-2-YL]-1-(2,3,4-TRIFLUOROBENZOYL)AZETIDIN-3-OL, 95.0%, 250mg

4-Bromo-N-ethyl-6-methyl-7-oxo-1h-pyrrolo[2,3-c]pyridine-2-carboxamide, 98%, 500mg

2-Chloro-5,5-dimethyl-1,3,2-dioxaphosphorinane 2-oxide, 97.0%, 10g

6-Methoxy-1H-pyrrolo[3,2-c]pyridine, 95.0%, 100mg

METHYL 2-AMINO-5-BROMO-4-FLUOROBENZOATE, 95.0%, 1g

5-Methylpyridine-2(1H)-thione, 95.0%, 250mg

GC capillary column ROTI®Cap-5 MS, 30 m, 0.32 mm, 0.50 µm, 1 Piece(s)

3-Bromo-5-(morpholin-4-yl)-7H-thieno[3,2-b]pyran-7-one, 97%, 100mg